glaucoma

Jimmie's family kept glaucoma a secret for years, but his wife's encouragement led to a timely diagnosis by an eye doctor. The article emphasizes the importance of knowing family history to combat glaucoma, a leading cause of blindness.

Emily experiences vision loss due to glaucoma and macular degeneration but maintains her independence and focuses on making the most of each day. The article highlights her resilience and proactive approach to life despite her condition.

Glaucoma, referred to as the 'Silent Thief of Sight,' is the leading cause of permanent blindness. The article emphasizes the importance of consulting an eye doctor, especially for individuals with a family history of glaucoma.

The first human trial of an experimental gene therapy aims to test the safety of cellular reprogramming to rejuvenate aging cells, with initial focus on treating glaucoma. The trial, sponsored by Life Biosciences co-founded by David Sinclair, represents a critical step in validating the potential of epigenetic reprogramming to address age-related diseases.

Life Biosciences has initiated a trial testing an experimental treatment for glaucoma by injecting a reprogramming therapy into a volunteer's eye to regenerate healthy nerves. The approach aims to reverse aging by resetting cells to a younger state, building on past strategies like targeting telomere attrition and cellular senescence, though recent trials of senescence clearance in humans showed mixed results.

A study suggests sleeping without a pillow may reduce eye pressure in glaucoma patients by preventing neck strain and improving blood flow. Researchers link elevated pillow use to increased intraocular pressure, while experts emphasize balancing sleep posture for individual health needs.